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1. INTRODUCTION 
 2 
 
An increasing amount of scientific evidence proposes that oxidative stress and the resulting 
cellular damage are responsible for the process of aging and the evolution of various diseases (1). 
During the last years, a great amount of papers has been published, which document the positive 
correlation between an increase of certain markers of oxidative stress and the process of aging. 
Consequently, cells of older organisms have a higher load of oxidatively damaged macromolecules, 
like nucleic acids, lipids and proteins.  
In the following paper, the focus will be on a specific kind of oxidative modification of 
proteins, namely carbonylation, and a possibility to use it as a biomarker of aging (2). 
 
 
1.1. Aging 
 
1.1.1. Definition 
 
Aging is a highly complex biological phenomenon, affecting all biological systems, 
characterized by a continuous and irreversible reduced capacity of the living organism to withstand 
the burden of everyday life, increasing the risk of morbidity and mortality (3,4).  
 
 
1.1.2. Chronological and biological age 
 
It is common knowledge that the life expectancy (the average life span of a general 
population) of humans is constantly rising globally, although the underlying process of aging hasn’t 
changed. It is attributable to several factors, including better hygiene, wealth, education and most 
importantly due to better public health. With increased longevity of humans, also grows the 
population of older people, and with this age-related sequela like diseases and impairments. That 
consequently leads to an increased demand of prevention and intervention strategies to support 
healthy aging (5,6). 
It has been mentioned many times by geriatric specialists that between humans of the same 
chronological age, differences exist in the pace of aging. That means that the chronological age, 
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which is the age of a person measured from birth to a given date, is different to the biological age, 
which in turn measures more specifically the functional and physiological status (7-9). 
 The variation in aging processes between individuals is partially attributable to tissues 
aging at different velocities and thus leading to the fact that for any individual’s chronological age 
the values for biological age can differ broadly. Conclusively the biological age is thought to 
correlate with the personal variations in longevity and timing and degree of the aging process (8, 
9). “Biologically older“ refers to humans whose function is poorer in comparison to others of the 
same chronological age, the contrary describes humans with better function and they are therefore 
called “biologically younger“ (10).  
The biological age can not only give an approximation of the individual’s present general 
status and remaining life expectancy, it may also serve as a measure of relative fitness, help in 
determining the personal risk for age-related disorders and disability and to predict mortality 
independent from chronological age (9).  
 
 
 
1.2. Biomarker 
 
Over the last decades, plenty of research has been conducted on how to measure and 
evaluate biological age in humans. 
In order to assess the rate of aging, the classical quantitative evaluation is based on the 
analysis of mortality curves, which means that probands have to be followed up until their death to 
be able to determine their biological age at any time during life. For that reason, a reliable 
measurement of the state of aging, namely the functional decline and a prediction of the remaining 
personal life expectancy at any level of a living proband is not attainable with this method. That 
dilemma raises the need for a workable test strategy and parameter, which would be able to 
determine age-related changes in body function and composition, predict the likelihood of onset 
morbidity and the remaining life span. That parameter is named “biological marker of aging” (4). 
Various biological parameters, the so called biomarkers of aging, have been found to 
correlate with the physical and functional status of an organism and therefore more precisely with 
the biological age. Baker and Sprott defined biomarkers of aging in 1988 as follows: ‘‘A Biomarker 
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of Aging (BoA) is a biological parameter of an organism that either alone or in some multivariate 
composite will, in the absence of disease, better predict functional capability at some late age, than 
will chronological age’’ (3). 
 
 
 
1.3. Carbonylation 
 
 Carbonylation is a form of protein oxidation, which is modified by reactive oxygen species 
(11). It is a post-translational modification, produced by the addition of carbonyl groups to proteins. 
This process is caused by reactions between protein amino acid residues and reactive oxygen 
species (ROS) (12). ROS- induced post-translational protein modifications can be either of 
reversible or irreversible nature. Besides carbonylation, being an irreversible modification, 
reversible protein modifications like S-glutathionylation, S-nitrosation and methionine 
sulfoxidation exist. These harmless events comprise a two-fold role of modulation of protein 
function (redox regulation) and protection from irreversible oxidation (13-15). 
Carbonylation of proteins is an irreversible and non-enzymatic transformation, which often 
results in a loss of function of proteins and longstanding deleterious cellular outcomes (12). 
During the process of carbonylation, carbonyl groups are attached to proteins by a number 
of distinct oxidative pathways. Either by a direct oxidation reaction of ROS with the protein amino 
acid residues like proline, arginine, lysine and threonine and from the oxidative modification of the 
protein’s backbone or by an indirect reaction. The indirect reaction refers for example to lipid 
peroxidation, in which lipids react with ROS or glycation/glycoxidation reaction, which apply to 
sugars and ROS producing reactive carbonyl derivatives, like ketones and aldehydes. These 
reactive carbonyl derivatives may interact with amino acids, such as cysteine, histidine and lysine 
in a secondary reaction, forming advanced glycation end-products (AGEs) and advanced 
lipoxidation end-products (ALEs) (12,16). 
By reflecting cellular damage induced by multiple forms of ROS, protein carbonylation is 
the most widely popular biomarker for oxidative damage to proteins (17). Their products are 
chemically stable and uncomplicated to identify after being modified with dinitrophenylhydrazine 
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by different methods of immunostaining, like ELISA, fluorescence microscopy and immunoblot 
(18). 
 
 
 
1.4. Reactive oxygen species and free radicals 
 
Reactive oxygen species is the term for a number of free radicals and reactive molecules 
originating from molecular oxygen (19). Free radicals are molecular species, which carry an 
unpaired electron in an atomic orbital, thereby frequently resulting in an unstable and highly 
reactive state. They are able to either accept an electron from or donate an electron to a different 
molecule, consequently acting like reductants or oxidants (20). 
In the human body, ROS are derived from endogenous or exogenous pathways, such as 
exposition to irradiation (x-rays), atmospheric pollutants, like ozone and cigarette smoke and 
industrial chemicals or xenobiotics to name only a few (21,22). 
Endogenously, ROS can be generated enzymatically or non-enzymatically. The generation 
of ROS is primarily connected to the non-enzymatic pathway of one-electron carriers in the 
mitochondrial respiratory chain, in which leaking electrons are directly transferred to oxygen. That 
process is supposed to be the primary source of O2−• in most tissues. 
In the living organism in aerobic conditions, reactive oxygen species are formed by a 
stepwise reduction (of electrons) of molecular oxygen (O2) through the addition of one electron 
each to superoxide (O2−•), then to hydrogen peroxide (H2O2), afterwards producing a hydroxyl 
radical (•OH) and eventually formation of water (H2O) (Figure 1). 
Examples for free radicals are superoxide anion and hydroxyl radical, indicated by the dot 
in their chemical nomenclature. Hydrogen peroxide (H2O2) and singlet oxygen (1O2) are 
examples for nonradical oxidants (23). 
Enzymatic sources comprise for instance NADPH oxidases on cell membranes on 
macrophages and polymorphonuclear cells and cytochrome P450-dependent oxygenases 
(19,22,24). 
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Figure 1: „Complete and incomplete reduction of molecular oxygen. The production of 
specific reactive oxygen species by single electron additions (e-)“ (25).   
 
 
 
1.5. Oxidative stress and antioxidants 
 
In 1985, Helmuth Sies was the first one to define oxidative stress, which is the imbalance 
between oxidants (ROS, free radicals) and antioxidants in favor of the oxidants. It can apply to 
situations in which the steady-state ROS concentration is either transiently or chronically increased, 
thereby impeding the cellular metabolism, its regulations, and inducing various post-translational 
modifications, such as carbonylation, which in turn may lead to consequences for cell physiology, 
like loss of function of the targeted cells (22,26). 
Oxidative stress can be the consequence of the reduction of low molecular mass antioxidant 
reserves, an elevated level of endo- and exogenous ROS production and a reduced generation or 
an inactivation of antioxidant enzymes (26).  
Oxidative stress can be divided into chronic oxidative stress and acute oxidative stress, 
depending on the time of the elevated ROS levels. Acute oxidative stress describes a situation in 
which temporarily enhanced ROS levels cannot be controlled by the antioxidant system, but after 
an initial increase, they return back to a stage manageable by the defense system of cells. On the 
contrary, in chronic oxidative stress, antioxidant mechanisms, like enhanced expression of 
antioxidant and related enzymes cannot balance elevated ROS amounts and the raised ROS levels 
will settle at a new steady level. This eventually leads to adjustments of various cellular 
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components and considerably perturbing homeostasis. During the last years, plenty of research has 
shown that chronic oxidative stress is connected to many pathologies, like cardiovascular and 
neurodegenerative diseases, cancer and diabetes mellitus  (26). 
According to Halliwell & Gutteridge in 1989, the term antioxidant defines „any substance 
that, when present at low concentrations compared with that of an oxidizable substrate, 
significantly delays or inhibits oxidation of that substrate.“ (27). 
 These substances can be of enzymatic and non-enzymatic nature. Antioxidant enzymes, 
acting like radical scavengers, establish the main antioxidant defense system of the organism (22). 
They achieve their action by either preventing reactive oxygen species to be formed or by 
eliminating them before they can exert their negative effects on vital compounds of the cell, namely 
DNA, lipids and proteins (28). As stated above, the basic function of the antioxidant system is to 
keep the ROS at an ideal level, because ROS are also believed to participate in cellular functions 
like redox signaling (29). 
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2. OBJECTIVES 
 9 
 
The main aim of this study was to investigate the role of carbonylation in aging and its role 
as biomarker for estimation of age. The Thesis is a part of the Module 1 of the CarboNyx project 
by the Croatian Science Foundation. The module 1 was built with these goals:  
 
Primary module objective: Measure protein carbonylation in pre-selected healthy subjects 
 
Expected results: Determination of the pattern of changes in protein carbonylation associated with 
healthy ageing 
 
Applicability: The use of protein carbonylation biomarkers as a tool to define biological age (as 
opposed to the chronological age), but also to use it as a mean of molecular well-being 
measurement (where small changes of specific protein carbonylation could reflect selective 
biological processes associated with stress, strain and possibly even early stages of some diseases). 
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    3. MATERIALS AND METHODS 
 11 
This study was based on a subsample of the 10,001 Dalmatians project, which is the largest 
research-oriented biobank in Croatia. The main objective of this program is to create a 
comprehensive resource for the study of genetic, environmental and social determinants of health 
and diseases with emphasis on chronic diseases, which are the leading cause of death in Croatia 
and other developed countries (30). 
For the purpose of this study, we selected a subset of 50 healthy subjects from the island of 
Korčula. The status of a healthy subject was based on the detailed analysis of their medical records, 
in which there were no indications of the existence of any kind of chronical disease that could have 
affected the result. Their corresponding biological sample of plasma was taken from the 10.001 
Dalmatians freezer and used in the analysis – no additional contact was made with the subjects, 
therefore no additional ethical approval was sought.  
In addition to this, we had also used a number of measurements from the same dataset, 
allowing us the comparative analysis of the carbonylation and other measured variables. These 
included basic demographic data, anthropometric measurements, cognitive testing results and 
biochemical analysis of their serum and plasma.  
 
3.1. Protocol 
  
Total carbonylation and expression of the proteins in plasma samples (1D 
electrophoresis) 
Plasma samples were depleted of most abundant proteins (albumin and IgG) using Multiple 
Affinity Removal Column HAS/IgG Column, 4.6 x 50 mm (Agilent Technologies). Before 
injection onto a MARS column, the human plasma was diluted 4X with Buffer A (Agilent 
Technologies). The samples were transferred to a 0.22 µm cellulose acetate spin filter (Spin-X 
centrifuge tube filter, Costar) and centrifuged for a 1 min at 16000 x g to remove particulates. 
Filtrate was collected into HPLC vial.  
HPLC lines were purged with 50% isopropanol in water to ensure the removal of all unwanted salts 
and organics. Buffer A and buffer B (Agilent Technologies) were set as the only mobile phases, 
and Buffer A was used as a needle wash. Two blanks (buffer A) were injected (Vinj = 50 µL) and 
run without column by method described in Table 1. 
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Column was attached and equilibrated in buffer A for 4 min at a flow rate of 1 mL at room 
temperature. Samples were injected (Vinj = 50 µL) and run by method described in Table 1. 
Flow-through fraction from 1.1 – 9 min (λ = 280 nm) was collected and stored at  
-20°C until processed further. 
 
 
    Table 1. LC method for 4.6 x 50 mm column. 
Time (min) %B 
Flow rate  
(mL/min) 
0.00 0 0.25 
10.00 0 0.25 
10.01 0 1.00 
12.00 0 1.00 
12.01 100 1.00 
15.00 100 1.00 
15.01 0 1.00 
21.00 0 1.00 
 
 
 
 
 13 
Buffer exchange to 1X PBS was performed using 3kDa Amicon Ultra- 4mL centrifugal 
filter devices (Merck). Devices were spun at 13310 x g for 40 min, filtrate was removed, 3.0 mL 
of 1X PBS was added to concentrated sample and were spun again at 13310 x g for 40 min. 
Concentrated sample was collected.  
Sample concentration was measured using Bradford method and the appropriate amount of 
sample was diluted with 1X PBS for further staining with CF647DI-aminooxy dye (Biotium). 
Staining of the samples was performed over night at 4°C and 600 rpm to ensure marking of the all 
aldehydes and ketones. 
For the SDS-PAGE were 8% resolving and 5% stacking gels prepared according to  
Table 2. 
 
 Table 2. Resolving and stacking gels for SDS-PAGE (4 gels in excess). 
Solution components 
Resolving gel  
(8 %) 
Stacking gel  
(5 %) 
Component volumes (mL) 
H2O 11.5 2.8 
40 % Acrylamide mix 6.7 0.83 
0.5 M Tris, pH 6.8 / 1.25 
1.5 M Tris, pH 8.8 6.3 / 
10 % SDS 0.25 0.05 
10 % APS 0.25 0.05 
TEMED 0.015 0.005 
 
 
Gels were run at 70 V for half an hour until samples run through stacking gel, after which 
the current was increased to 130 V. The last size band of proteins on the gels was around 20-25 
kDa. Gels were then stained with Serva purple dye (Serva) to determine total protein expression. 
Gels were scanned by Typhoon scanner (GE Healthcare) at appropriate wavelengths and data was 
analyzed in TotalQuant software (TotalLAb). 
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3.2. Statistics      
 
All data were analyzed using descriptive and analytic statistical methods. These methods 
included the calculation of means and standard deviations, followed by the correlation analysis. 
This was based on both Spearman’s rant test and Pearson test, based on the data distribution and 
underlying assumptions. Data fitting and trend analysis was based on the MS Excel built-in 
functions, which provided the opportunity to estimate the variance explained by the model. The 
final analytic step was based on the cross-validation approach and imputation analysis. The dataset 
was firstly split in two equal sized subsets, and then the chronological age information was retained 
for only the remaining half of the subjects. This allowed for the opportunity to impute the remaining 
age data, based on the gender and carbonylation levels. The same process was performed five times 
for each of the two sub-sets, creating a total of five complete sets of the predicted age data. This 
data was then used in the distribution analysis, in an attempt to provide an estimate of the possibility 
to use carbonylation as an ageing predictor in larger datasets. The correlation and imputations were 
performed in IBM SPSS (ver 21, IBM, Armonk, NY: USA).  
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   4. RESULTS 
 16 
A total of 50 randomly selected healthy subjects were included in this study. There were 18 
men (36.0%) and 32 women (64%), reflecting higher percentage of women in the original study. 
The average age was 48.33±18.48 years for men and 47.97±14.09 years for women, what was not 
a significant difference (P=0.938). The overall one-dimensional carbonylation was 0.263±0.096 
for men and 0.245±0.103 for women, yielding no significant difference (P=0.491).  
The initial comparison of the chronological age with the overall 1D carbonylation suggested 
the existence of the marginally significant correlation, under a non-linear assumption (Spearman 
rank: P=0.046, r=0.283) and even stronger correlation under the linear assumption (Pearson’s 
correlation: P=0.006, r=0.381), for both genders in a pooled analysis (Figure 2). Breakdown 
according to gender suggested that the pattern was retained or marginally retained in women 
(P=0.030, r=0.384 for linear and P=0.090, r=0.304 for non-linear), while in men the pattern was 
dissipated (P=0.108, r=0.392, P=0.203, r=0.315, respectively). 
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 Figure 2. Scatterplot of age vs total 1D carbonylation, by gender 
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The more in-depth analysis had suggested the existence of two relatively separate sub-
populations in men, broadly suggesting overall lower values in the younger men and more diverse 
values in elderly men (Figure 3). Fitting of a linear function suggested that the percent of variance 
explained was 15.3% (Figure 3). The similar pattern was observed in women, with possibly even 
stronger patter of greater carbonylation values in older women, with 14.7% of variance explained 
(Figure 4).  
 
 
 
 
 
   Figure 3. Scatterplot of total 1D carbonylation with age, men 
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Figure 4. Scatterplot of total 1D carbonylation with age, women 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 0,0028x + 0,1099
R² = 0,1474
0
0,1
0,2
0,3
0,4
0,5
0,6
0 10 20 30 40 50 60 70 80
Total 1D carbonylation, women
 20 
Out of the large number of variables that were then correlated to carbonylation, several 
variables were significant, namely central augmentation index, pulse wave velocity and standard 
progressive matrices, besides brachial circumference and two more cognitive measures, verbal 
fluency test and Rey Auditory Verbal Learning Test, which were marginally significant (Table 3). 
Notably, directions of the three significant correlations were all in line with the expectations – 
higher carbonylation was correlated to worse result of standard progressive matrices, higher pulse 
wave velocity and central augmentation index (Table 3; all analyzed variables are presented in 
Table 4).  
 
 
 
 
 
 
Table 3. Results of correlations of carbonylation with various variables  
 
Variable P r 
Cognition: standard progressive matrices 0.021 -0.345 
Pulse wave velocity 0.031 0.305 
Central augmentation indeks 0.042 0.289 
Brachial circumference 0.050 0.279 
Cognition: Rey Auditory Verbal Learning Test (RAVLT) 0.054 -0.289 
Cognition: verbal fluency test (S) 0.097 -0.251 
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Table 4. Correlation coefficients of carbonylation vs. all other numeric variables 
 
Variable P r 
Height (cm) 0.691 -0.059 
Weight (kg) 0.779 0.042 
Finger-sternal length (cm) 0.155 -0.204 
Waist circumference (cm) 0.186 0.190 
Hip circumference (cm) 0.396 0.124 
Brachial circumference (cm) 0.050 0.279 
Head circumference (cm) 0.175 0.195 
Neck circumference (cm) 0.428 0.115 
Brachial width (cm) 0.705 0.080 
Biceps skinfold, M1 0.171 -0.197 
Biceps skinfold, M2 0.311 -0.146 
Biceps skinfold, M3 0.497 -0.098 
Triceps skinfold, M1 0.210 -0.180 
Triceps skinfold, M2 0.353 -0.134 
Triceps skinfold, M3 0.368 -0.130 
Abdominal skinfold, M1 0.991 0.002 
Abdominal skinfold, M2 0.955 0.008 
Systolic BP, M1 0.878 -0.022 
Systolic BP, M2 0.401 0.122 
Diastolic BP, M1 0.467 -0.105 
Diastolic BP, M2 0.117 0.224 
Cognition: standard progressive 
matrices 
0.021 -0.345 
Pulse wave velocity 0.031 0.305 
Cognition: SPM 0.021 -0.345 
Cognition: verbal fluency (F) 0.185 0.201 
Cognition: verbal fluency (A) 0.204 -0.193 
Variable P r 
Cognition: verbal fluency (S) 0.097 -0.251 
Variable P r 
Cognition: RAVLT  0.054 -0.289 
Cognition: Mill Hill scale 0.504 -0.102 
EPQ_P 0.885 -0.022 
EPQ_E 0.807 -0.037 
EPQ_N 0.354 -0.142 
EPQ_L 0.137 0.225 
Serum creatinine 0.714 0.053 
Serum uric acid 0.216 0.178 
Serum glucose 0.147 0.208 
Serum cholesterol 0.597 0.077 
Serum triglycerides 0.525 0.092 
Serum HDL 0.689 -0.058 
Serum LDL 0.567 0.083 
Serum VLDL 0.472 0.104 
Serum calcium 0.154 0.205 
Serum albumin 0.616 -0.073 
HbA1c 0.228 0.173 
HbA1c_ifcc 0.236 0.171 
Fibrinogen 0.662 -0.064 
Order of birth 0.125 0.220 
Number of siblings 0.525 0.096 
Marital age 0.359 -0.151 
Spouse age at marriage 0.058 -0.307 
Number of children 0.844 0.029 
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The multivariate model with gender and carbonylation in prediction of chronological age 
yielded only 14.6% of variance, while a random split in two subset yielded variances of 5.3% and 
7.8%, suggesting strongly underpowered analysis (Table 5). Notably, carbonylation was a 
significant predictor of age in the full model, yielding a P value of 0.007 (Table 5).  
 
 
Table 5. Multivariate modelling with two steps of cross-validation, predicting age with gender and 
carbonylation 
 
 Cross-validation 1 Cross-validation 2 All data 
 F P F P F P 
Model 5.373 0.030 8.044 0.010 11.082 0.002 
Gender 0.001 0.997 0.578 0.455 0.031 0.860 
Carbonylation 1.833 0.190 0.436 0.516 8.007 0.007 
R2 7.8 5.3 14.6 
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The simulation results suggested that the overall prediction was of moderate to large effect, 
with the existence of an exponential trend and the overall 59.06% of explained variance in 
comparison of the observed vs. predicted age (Figure 5). Simulation results indicated that the extent 
of difference of observed vs. predicted age was greater in elderly and in younger subjects, with 
significant quadratic trend (F=8.03, P=0.002; Figure 6). 
 
 
 
 
 
 
Figure 5. Comparison of the observed vs. predicted age from the simulation model 
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Figure 6. Scatterplot of age difference (predicted vs. observed) vs. observed age, with quadratic 
trend fit 
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5. DISCUSSION 
 26 
The results of this study suggest that carbonylation is linked to chronological age, but that 
one-dimensional carbonylation has limited power in age prediction. This is based on the finding of 
certain amount of changes, but also on the substantial variation that was seen in the analyzed 
dataset. The extent of variation of carbonylation was rather large, while the percent of variance of 
predicted age that was explained by carbonylation was at best-case scenario close to only 15%. 
The results also show that the dataset was too small for more elaborate findings, suggesting that 
much larger datasets will be needed to refine these results and establish the possibility of use of 
carbonylation as a biomarker of ageing. These estimates were more reliable in the middle-aged, 
while they seemed to be less reliable in younger and more elderly. While this could simply be an 
artefact of the sample size, it could also point towards greater extent of biological variability in 
younger and in very old subjects.  
The study shows that carbonylation values are more diverse in elderly men than the values 
in younger men. A reasonable explanation for that fact is that biological controlling mechanisms, 
namely antioxidants, which act like scavenger systems for ROS attenuate with age. This finding is 
consistent with a study from 2006 conducted by Rizvi et al., in which they could point out that 
plasma antioxidant potential, which is the potential to neutralize oxidative stress, decreases as a 
function of age. They demonstrated it based on measurements displaying a decline of ferric 
reducing ability of plasma (FRAP) values (31). 
Our results present a similar manner of carbonylation values in women, displaying lower 
values in younger women, but an even stronger erratic pattern of carbonylation in elderly women. 
This finding is possibly a consequence of the decline of estrogen levels in women after menopause 
to a level equal to those of age-matched men. C. Borrás et al. published 2003 a paper using an 
animal model with rats, demonstrating that mitochondria in females show a larger antioxidant gene 
expression and a smaller oxidative damage compared to males. This is a consequence of the activity 
of estrogens, which by means of intracellular signalling pathways upregulate nuclear expression of 
antioxidant enzymes, and thereby protecting the cells from the damaging effect of oxidative stress 
(32). In addition to that finding, C. Borrás et al. were able to show that besides upregulating 
antioxidant enzymes, estradiol targets estrogen receptors directly within the mitochondria, and as 
a consequence has a direct antioxidant and protective effect on isolated mitochondria (33). The 
previously mentioned studies explain our measurements that as soon the levels of estrogen fall 
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down after the start of menopause in women, the protective effect of estrogen ceases and the erratic 
pattern of carbonylation becomes stronger.  
Notably, several interesting correlations were observed, with pulse wave velocity and 
cognition. The aortic pulse wave velocity (PWV) is the speed at which the arterial pulse travels 
through the circulatory system and is connected to the stiffness of the arteries. In his Croonian 
lecture from 1808, Thomas Young was the first scientist to describe the relationship between the 
elastic properties of arteries and the pulse wave velocity. Generally, the PWV is described by the 
Moens-Korteweg equation. In the process of aging, there are several changes occurring in the 
circulatory system, the central elastic arteries stiffen, diastolic pressure decline, and central systolic 
and pulse pressures are augmented because of elevated PWV and early return of reflected waves 
to the heart from the periphery (34). 
The augmentation index (AI) is another tool, independent from the pulse wave velocity, 
which indirectly measures arterial stiffness. It has been scientifically shown that the AI increases 
with age (35). Furthermore research has shown that the compliance of arteries in the human 
circulatory system decreases with age (36) and that even in the absence of cardiovascular disease, 
the decline in arterial elasticity starts in childhood (37). To calculate the augmentation index, the 
augmentation pressure has to be divided by the pulse pressure x 100 to obtain a percentage. The 
augmentation pressure describes the contribution of the wave reflection to the systolic arterial 
pressure. It is acquired by the measurement of the reflected wave, which propagates from the 
periphery to the center. While aging, the AI increases with enhanced stiffening of the arteries, 
which leads to a faster propagation of the advancing pulse wave and a more quickly reflected wave 
(35). 
Our results indicate a significant correlation between high levels of carbonylation and pulse 
wave velocity and carbonylation and the augmentation index. A higher and therefore more 
unfavorable level of PWV and AI correlate with higher carbonylation. Increased values for PWV 
and AI point to a decreased arterial compliance, which in turn is concomitant with increased age.   
Standard Progressive Matrices (SPM) are valuable tools in the diagnostic of intelligence 
and evaluation of the intellect through abstract reasoning tasks. They nonverbally assess the 
cognitive capability of humans in a broad spectrum and are mostly independent of education, 
nationality and physical constitution of the test subject. Of three instruments, which are known as 
 28 
the Raven’s Progressive Matrices, SPM is the first and most widely used. The other two matrices 
are the Coloured Progressive Matrices (CPM) and the Advanced Progressive Matrices (APM).  
We found out, that an increased level of carbonylation is associated with a worse 
performance in the Raven Standard Progressive Matrices test. Researchers from the university of 
Maastricht found out that also old age is associated to lower SPM test performance (38). 
The most salient limitation of this study is small sample size, leading to underpowered 
analysis. Increasing the sample size would therefore be considered as the initial step in elucidating 
the link between carbonylation and ageing. Furthermore, we have measured only a single-
dimensional carbonylation amount, which is the total sum of carbonylation of all serum proteins. 
It could easily be that the there are changes of specific proteins, suggesting that two-dimensional 
carbonylation is needed in terms of improvement of laboratory procedures. The cohort of subjects 
could also be standardized in a more elaborate way, in order to control for the most obvious 
confounding factors, such as diet, lifestyle and exercise.  
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6. CONCLUSION 
 30 
 
1. Carbonylation correlates to chronological age, suggesting that it might be a useful biomarker of 
aging 
2. However, as it is difficult to provide a real estimate of biological aging, the usefulness of 
carbonylation remains of limited use. We need to develop in two directions, namely measuring 
carbonylation in unhealthy subjects (aiming to see the association with morbidity), but also 
developing a protein-specific carbonylation estimate, which would allow a refined analysis.  
3. Carbonylation was correlated to a number of variables that are known to deteriorate in elderly, 
like the pulse wave and cognition, further supporting the possibility to use it as a biomarker.  
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7. SUMMARY  
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Title: Plasma Protein Carbonylation as Biomarker for Estimate of Age 
 
Objectives: The main aim of this study was to investigate the role of carbonylation in ageing and 
its role as biomarker for estimation of age 
 
Materials and methods: The data from the 10.001 Dalmatians biobank were used, focusing on 
the 50 healthy subjects from the island of Korčula. One-dimensional carbonylation of plasma was 
measured, using HPLC. The results were correlated to a number of available variables from this 
dataset.  
 
Results: The results of this study suggest that carbonylation is linked to chronological age, but that 
it has limited power in individual age prediction (Spearman rank: P=0.046, r=0.283, Pearson’s 
correlation: P=0.006, r=0.381). Furthermore, carbonylation values were more diverse in elderly 
than the young men, the percent of variance explained was 15.3%. Similar to men, carbonylation 
values are lower in younger women, but show a stronger erratic pattern of carbonylation in elderly 
women, explained with a variance of 14.7%. Additionally, there is correlation between high levels 
of carbonylation and Pulse Wave Velocity and the Augmentation Index. A higher and therefore 
more unfavorable level of PWV and AI correlate with higher carbonylation and older age (PWV: 
P=0.031, r=0.305, AI: P=0.042, r=0.289). Last but not least, an increased level of carbonylation is 
associated with a worse performance in the Raven Standard Progressive Matrices test (P=0.054, 
r=-0.289). 
 
 
Conclusion: Carbonylation correlates chronological age, but either larger sample sizes or the use 
of two-dimensional carbonylation is required before individual age prediction can be more reliable.  
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8. CROATIAN SUMMARY  
 34 
 
Naslov: Karbonilacija proteina plazme kao biomarkera za procjenu dobi 
 
Ciljevi: Glavni cilj ove studije bio je istražiti ulogu karbonilizacije u starenju i mogućnosti 
korištenja za procjenu starosti 
 
Materijali i metode: Upotrijebljeni su podaci iz biobanke 10.001 Dalmatinac, s naglaskom na 50 
zdravih ispitanika s otoka Korčule. Jednodimenzionalna karbonilacija plazme mjerena je pomoću 
HPLC-a. Rezultati su korelirani s raznim mjerenjima iz ovog projekta.  
 
Rezultati: Rezultati ovog istraživanja sugeriraju da je karbonilacija povezana sa starenjem, ali da 
ima ograničenu snagu u predviđanju starosti pojedinca, (Spearman rank: P=0.046, r=0.283, 
Pearson’s correlation: P=0.006, r=0.381). Nadalje, vrijednosti karbonilacije bile su raznovrsnije 
kod starijih muškaraca, postotak objašnjenje varijacije iznosio je 15,3%. Slično muškarcima, 
vrijednosti karbonilacije niže su kod mlađih žena, ali u starijim dobnim skupinama pokazuju 
mnogo veću raznolikost, objašnjeno varijacijom od 14,7%. Osim toga, postoji korelacija između 
visokih nivoa karbonilacije i brzine pulsnog vala (PWV: P=0.031, r=0.305, AI: P=0.042, r=0.289). 
Posljednje, ali ne i najmanje važno, povećana razina karbonilacije povezana je s lošijom rezultatom 
kognitivnih testova (P=0.054, r=-0.289).  
 
 
Zaključak: Karbonilacija korelira sa starenjem, ali za provedbu osobne procjene dobi potrebna je 
ili veća veličina uzorka ili upotreba dvodimenzionalne karbonilizacije. 
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